Atlas Trials

Effects of Acute and Chronic Empagliflozin Heart Failure

Clinical trial NCT05553938 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05553938
Sponsor
Yale University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure
Start date
2023-08-04
Primary completion
2026-05-08
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.